Doxycycline to treat levodopa-induced dyskinesias in Parkinson's disease: a preliminary study / Doxiciclina no tratamento das discinesias induzidas pela doença de Parkinson: um estudo preliminar

Abstract Background Levodopa-induced dyskinesia (LID) is a common motor complication of levodopa therapy in patients with Parkinson's disease (PD). Doxycycline is a widely used and inexpensive tetracycline with anti-inflammatory properties. Objective To evaluate the efficacy and safety of doxycycline in patients with PD and LID. Methods This was an open-label, uncontrolled, single-arm, single-center, phase 2 proof-of-concept study in patients with PD with functional impact of dyskinesia, which used levodopa three times daily, in a movement disorders clinic in Brazil. Participants were treated with doxycycline 200 mg/day for 12 weeks, with evaluations at baseline, week4, and week 12 of treatment. The primary outcome measure was the change from baseline in the Unified Dyskinesia Rating Scale (UDysRS) total score at week 12, evaluated by two blinded raters. Key secondary outcomes measures were OFF time and ON time with troublesome dyskinesia in the PD home diary. Results Eight patients with PD were treated and evaluated. Doxycycline 200 mg/day reduced the UDysRS total score at week 12, compared with baseline (Friedman χ2 = 9.6; p = 0.008). Further, doxycycline reduced the ON time with troublesome dyskinesia (Friedman χ2 = 10.8; p = 0.004) without worsening parkinsonism. There were no severe adverse events, and dyspepsia was the commonest event. Conclusion In this preliminary, open-label and uncontrolled trial, doxycycline was effective in reducing LID and safe after a 12-week treatment. Further well-designed placebo-controlled clinical trials with a longer duration and a larger number of participants are needed. Clinical trial registration https://ensaiosclinicos.gov.br, identifier: RBR-1047fwbf

Resumo Antecedentes A discinesia induzida por levodopa (DIL) é uma complicação motora comum da terapia com levodopa em pacientes com doença de Parkinson (DP). A doxiciclina é uma tetraciclina amplamente usada e barata, com propriedade anti-inflamatória. Objetivo Avaliar a eficácia e segurança da doxiciclina em pacientes com DP e DIL. Métodos Este foi um estudo aberto, não-controlado, de braço único, monocêntrico, fase 2 e de prova de conceito, em pacientes com DP e impacto funcional das discinesias, que usavam levodopa três vezes ao dia, em um ambulatório de distúrbios de movimento no Brasil. Os participantes foram tratados com doxiciclina 200 mg/dia por 12 semanas, com avaliações na base, na semana 4 e na semana 12 do tratamento. A medida de desfecho primário foi a mudança no escore total da Unified Dyskinesia Rating Scale (UDysRS) da base à semana 12, avaliada por dois avaliadores cegos. As medidas-chave de desfecho secundário fora o tempo em OFF e tempo em ON com discinesia problemática. Resultados Oito pacientes com DP foram tratados e avaliados. A doxiciclina 200 mg/dia reduziu o escore total da UDysRS na semana 12, comparado com a avaliação inicial (χ2 de Friedman = 9.6; p = 0.008). Além disso, a doxiciclina reduziu o tempo em ON com discinesia problemática (χ2 de Friedman = 10.8; p = 0.004) sem piorar o parkinsonismo. Não houve eventos adversos graves, e dispepsia foi o evento mais comum. Conclusão No presente estudo preliminar, aberto e não-controlado, a doxiciclina foi eficaz em reduzir as DIL e segura após tratamento por 12 semanas. Estudos clínicos bem-desenhados e placebo-controlados adicionais, com duração mais longa e maior número de participantes, são necessários.

Deficiencia del transportador de glucosa tipo 1: aspectos clínicos, diagnóstico y terapéutica / Glucose transporter type 1 deficiency syndrome: clinical aspects, diagnosis, and treatment

El síndrome de deficiencia del transportador de glucosa tipo 1 es una enfermedad de causa genética, que involucra el gen SLC2A1. En general, se presenta durante los primeros años de vida con retraso en la adquisición de pautas madurativas, epilepsia farmacorresistente y desórdenes del movimiento. La clínica y la disminución de glucosa en líquido cefalorraquídeo permiten sospechar el diagnóstico, el cual debe ser confirmado mediante el estudio molecular del gen SLC2A1. Debido a que se trata de una enfermedad poco frecuente y de expresión clínica variable, el diagnóstico precoz suele representar un desafío para los equipos de salud. Este es importante, ya que la implementación de la terapia cetogénica logra controlar las manifestaciones clínicas y mejora el pronóstico a largo plazo. Presentamos una revisión sobre el déficit del transportador de glucosa tipo 1, que abarca sus características clínicas, bioquímicas, moleculares y terapéuticas.

Glucose transporter type 1 deficiency with a typical onset is a genetic disorder associated with the SLC2A1 gene. Usually appears during the first years of life with severe developmental delay, drugresistant epilepsy, and movement disorders. Diagnosis is suspected based on clinical manifestations and a low glucose level in cerebrospinal fluid, and should be confirmed by the molecular genetic study of the SLC2A1 gene. As it is a rare disease with variable clinical expression, early diagnosis is often challenging for the healthcare team. Nevertheless, this is important because early implementation of ketogenic therapy will lead to control of the clinical manifestations and a better long-term prognosis. Here we review the glucose transporter type 1 deficiency syndrome focusing on its clinical, biochemical, molecular, and therapeutic characteristics.

Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease / Níveis séricos baixos de ácido úrico e discinesia induzida por levodopa na doença de Parkinson

Abstract Background Levodopa is the most used and effective medication for motor symptoms of Parkinson disease (PD), its long-term use is associated with the appearance of levodopa-induced dyskinesia (LID). Uric acid (UA) is believed to play an important neuroprotective role in PD. Objective To investigate if serum UA levels are related with the presence of LIDs in PD patients. Also, we investigated the associations among UA levels and clinical features of PD. Methods We enrolled 81 PD patients (dyskinesia = 48; no dyskinesia = 33) in the present study. A blood sample was collected to evaluate serum UA levels, clinical evaluation included the following instruments: Montreal Cognitive Assessment (MoCA), Beck Depression Inventory II (BDI-II), MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Hoehn and Yahr (HY), and the sub-item 4.1 of MDS-UPDRS IV (score ≥ 1). Additional relevant clinical information was obtained by a clinical questionnaire. Results Serum UA levels were lower in the dyskinesia group when compared with the no dyskinesia group. The same result was found in the UA levels of both men and women. The multivariate analysis showed lower uric acid levels were significantly associated with having dyskinesia (odds ratio [OR] = 0.424; 95% confidence interval [CI]: 0.221-0.746; p= 0.005). Additional analysis verified that serum UA levels are inversely correlated with depressive symptoms, disease duration, MDS-UPDRS IV and time spent with dyskinesia. A positive correlation was found with age at onset of PD symptoms. Conclusions The present study provides a possible role of serum UA levels in LID present in PD patients.

Resumo Antecedentes A levodopa é a medicação mais utilizada e eficaz para os sintomas motores da doença de Parkinson (DP); seu uso a longo prazo está associado ao aparecimento de discinesia induzida por levodopa (LID). Acredita-se que o ácido úrico desempenhe um importante papel neuroprotetor na DP. Objetivo Investigar se os níveis séricos de AU estão relacionados com a presença de LID em pacientes com DP. Além disso, investigamos as associações entre os níveis de AU e as características clínicas da DP. Métodos Foram incluídos 81 pacientes com DP (discinesia = 48; sem discinesia = 33) no presente estudo. Uma amostra de sangue foi coletada para avaliar os níveis séricos de AU, a avaliação clínica incluiu os seguintes instrumentos: Avaliação Cognitiva de Montreal (MoCA), Inventário de Depressão de Beck (BDI-II), MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Hoehn and Yahr (HY) e o subitem 4.1 da MDS-UPDRS IV (escore ≥ 1). Informações clínicas relevantes adicionais foram obtidas por meio de um questionário clínico. Resultados Os níveis séricos de AU foram menores no grupo com discinesia quando comparados ao grupo sem discinesia. O mesmo resultado foi encontrado nos níveis de AU de homens e mulheres. A análise multivariada mostrou que níveis mais baixos de ácido úrico foram significativamente associados a ter discinesia (odds ratio [OR] = 0,424; intervalo de confiança (IC) de 95%: 0,221-0,746; p= 0,005). Análises adicionais verificaram que os níveis séricos de AU estão inversamente correlacionados com sintomas depressivos, duração da doença, MDS-UPDRS IV e tempo gasto com discinesia. Uma correlação positiva foi encontrada com a idade de início dos sintomas da DP. Conclusões O presente estudo fornece um possível papel dos níveis séricos de AU na LID presente em pacientes com DP.

Corea como primera manifestación de lupus eritematoso sistémico sin síndrome de anticuerpos antifosfolipídicos: reporte de caso y revisión de la bibliografía / Chorea as the first clinical manifestation of systemic lupus erythematosus without anti-phospholipid syndrome: case report and literature review

Resumen ANTECEDENTES: La corea gravídica es un padecimiento poco común, caracterizado por movimientos espontáneos irregulares, no predecibles, de duración breve, que cambian de localización sin secuencia definida, y que poseen la particularidad de ser involuntarios. En la actualidad, su incidencia se estima en 1 caso por cada 2275 embarazos. CASO CLÍNICO: Paciente de 30 años, 45 kg, talla 1.65 m, IMC 16.5, tensión arterial 110-78 mmHg, frecuencia cardiaca de 136 lpm, frecuencia respiratoria de 19 rpm, saturación de oxígeno 98%. Inició con movimientos coreicos a las 12 semanas de embarazo y titulación de anticuerpos antinucleares 1:320, anticuerpos anti-ADN de 150 UI/mL, C3 en 126 mg/dL y C4 en 31 mg/dL. Se estableció el diagnóstico de lupus eritematoso sistémico con base en los criterios de EULAR/ACR. A las 32 semanas tuvo amenaza de parto pretérmino y progresión, a pesar de la útero-inhibición, preeclampsia con criterios de severidad y manifestaciones neuropsiquiátricas con exacerbación de los movimientos coreicos. La resonancia magnética no reportó hallazgos patológicos y se descartó el síndrome de anticuerpos antifosfolipídicos secundario. Luego de la finalización del embarazo remitieron los movimientos involuntarios característicos de la corea gravídica. CONCLUSIÓN: El control prenatal en el primer trimestre es fundamental para un de-senlace favorable de las pacientes; el inicio temprano de la inmunoterapia es decisivo en los desenlaces perinatales pues disminuye la morbilidad y mortalidad asociadas. La corea es una manifestación clínica incapacitante, de ahí la importancia de identificar su causa e iniciar el tratamiento oportuno.

Abstract BACKGROUND: Chorea gravidarum is a rare condition characterised by irregular, unpredictable, spontaneous movements of short duration, changing location without defined sequence, and with the peculiarity of being involuntary. Currently, its incidence is estimated at 1 case per 2275 pregnancies. CLINICAL CASE: Patient aged 30 years, 45 kg, height 1.65 m, BMI 16.5, blood pressure 110-78 mmHg, heart rate 136 bpm, respiratory rate 19 rpm, oxygen saturation 98%. She started with choreic movements at 12 weeks of pregnancy and titration of antinuclear antibodies 1:320, anti-DNA antibodies 150 IU/mL, C3 at 126 mg/dL and C4 at 31 mg/dL. The diagnosis of systemic lupus erythematosus was established based on EULAR/ACR criteria. At 32 weeks she had threatened preterm labour and progression, despite utero-inhibition, preeclampsia with severity criteria and neuropsychiatric manifestations with exacerbation of choreic movements. MRI reported no pathological findings and secondary antiphospholipid antibody syndrome was ruled out. After termination of pregnancy the involuntary movements characteristic of chorea gravidarum subsided. CONCLUSION: Prenatal monitoring in the first trimester is essential for a favourable patient outcome; early initiation of immunotherapy is crucial for perinatal outcomes as it decreases associated morbidity and mortality. Chorea is a disabling clinical manifestation, hence the importance of identifying its cause and initiating timely treatment.

Evaluation of scapular dyskinesia in patients that underwent a latarjet procedure / Avaliação da discinesia escapular em pacientes submetidos à cirurgia de latarjet

ABSTRACT Objective: To quantitatively assess the scapular movement of patients who underwent Latarjet surgery and to identify if they present scapular dyskinesia (SD), as well as correlate with the clinic state and the elevation degree of the shoulder. Methods: A cross-sectional study was carried out at the Movement Analysis Laboratory (LAM), at the Institute of Physical Activity and Sport Sciences, that quantitatively evaluated, using spherical retroreflective markers, the scapular movements of the control group (10 volunteers) and 22 patients (23 operated shoulders) that had been submitted to Latarjet surgery, between 2011 and 2016, with at least one year postoperative. The results of the control group were used as a parameter of normality and compared to those of the operated group. Posterior inclination, superior rotation, and medial rotation of the scapula were evaluated at angles of 60°, 90°, and 120° of elevation, both in ascending and descending phases. The statistical analysis used was the multivariate variance (MANOVA), comparing the right and left sides of the control group and, subsequently, the control group with the postoperative group (p = 0.05 in all tests). Results: When comparing the mean of the results of the quantitative evaluation of the control group with the operated group, no statistically significant differences were found between the two groups and between the dominant and non-dominant sides of the control group. Conclusion: Latarjet surgery does not cause SD, although there are alterations in some plane of the scapular movements in the ascending and/or descending phase. Level of Evidence III, Retrospective Comparative Study.

RESUMO Objetivo: Avaliar, de forma quantitativa, o movimento escapular dos pacientes submetidos à cirurgia de Latarjet e identificar se apresentam discinesia escapular (DE). Além disso, correlacionar com a clínica e com o grau de elevação do ombro. Método: Estudo transversal realizado no Laboratório de Análise do Movimento (LAM), no Instituto de Ciências da Atividade Física e Esporte que avaliou de forma quantitativa, utilizando marcadores retro-refletivos esféricos, os movimentos escapulares do grupo controle (10 voluntários) e 22 pacientes (23 ombros operados), submetidos à cirurgia de Latarjet, entre os anos de 2011 e 2016, com pelo menos um ano de pós-operatório. Foram utilizados os resultados do grupo controle como parâmetro de normalidade e posteriormente comparados aos do grupo de pacientes operados. Avaliadas a inclinação posterior, rotação superior e rotação medial das escápulas nos ângulos de 60°, 90° e 120° de elevação, tanto na fase ascendente quanto na descendente. A análise estatística utilizada foi a multivariada da variância (MANOVA) comparando os lados direito e esquerdo do grupo controle e posteriormente o grupo controle com o grupo pós-operatório (p = 0,05 em todos os testes). Resultados: Ao compararmos a média dos resultados da avaliação quantitativa do grupo controle com o grupo dos operados, não foram evidenciadas diferenças estatisticamente significativas entre os dois grupos, assim como os lados dominante e o não dominante do grupo controle. Conclusão: A cirurgia de Latarjet não causa DE, apesar de haver alterações em algum plano dos movimentos escapulares na fase ascendente e/ou descendente. Nível de Evidência III, Estudo Retrospectivo Comparativo.

Research on kinect based training system for sports obstacle assessment / Pesquisa no sistema de treinamento baseado no kinect para avaliação de obstáculos esportivos / Investigación sobre el sistema de entrenamiento basado en kinect para la evaluación de obstáculos deportivos

ABSTRACT Objective: The study draws attention to designing a dyskinesia assessment system using a Kinect sensor to improve the efficiency of rehabilitation training. Methods: The login page design. Step 2: System functions setting. Relevant movement guidance content and rehabilitation evaluation content are incorporated in the system to make rehabilitation training efficient and orderly. Comprehensive data processing, evaluation, and export functions are necessary to reference rehabilitation physicians in diagnosis and treatment. Step 3: System modules design. Based on the system settings, corresponding functional modules have been designed and developed. With each module realizing its specific functions, it must be ensured that there is a certain degree of correlation between the modules. Step 4: The system function framework design. Results: A simple and comfortable login page is designed; 2. The system is capable of rehabilitation training and data management; 3. Specifically designed modules include sports collection module, rehabilitation training module, rehabilitation evaluation module, and information management module; 4. After logging in, the patient should first search for the rehabilitation plan in the rehabilitation training function module and then perform rehabilitation training regarding the rehabilitation plan. Kinect synchronously obtains patient sports information throughout the training process, and patients can obtain rehabilitation assessment information and automatically save it in the information management module. Conclusions: The Kinect-based dyskinesia assessment and training system designed in this study can heighten the efficiency of rehabilitation training for patients with dyskinesia, and it is highly suggested in clinical practice. Level of evidence II; Therapeutic studies - investigation of treatment results.

RESUMO Objetivo: O estudo chama a atenção para o projeto de um sistema de avaliação de discinesia usando sensor Kinect para melhorar a eficiência do treinamento de reabilitação. Métodos: O design da página de login. Etapa 2: configuração das funções do sistema. Conteúdo de orientação de movimento relevante e conteúdo de avaliação de reabilitação são incorporados ao sistema para tornar o treinamento de reabilitação eficiente e ordenado. Funções abrangentes de processamento, avaliação e exportação de dados são necessárias para fornecer referência para médicos de reabilitação em diagnóstico e tratamento. Etapa 3: Projeto dos módulos do sistema. Com base nas configurações do sistema, os módulos funcionais correspondentes foram projetados e desenvolvidos. Com cada módulo realizando suas funções específicas, deve-se garantir que haja um certo grau de correlação entre os módulos. Etapa 4: O design da estrutura de funções do sistema. Resultados: Uma página de login simples e confortável é projetada; 2. O sistema é capaz de treinamento de reabilitação e gerenciamento de dados; 3. Módulos especificamente projetados incluem módulo de coleta de esportes, módulo de treinamento de reabilitação, módulo de avaliação de reabilitação e módulo de gerenciamento de informações; 4. Após o login, o paciente deve primeiro pesquisar o plano de reabilitação no módulo de função de treinamento de reabilitação e, em seguida, realizar o treinamento de reabilitação com referência ao plano de reabilitação. O Kinect obtém de forma síncrona informações sobre esportes do paciente durante o processo de treinamento, e os pacientes podem obter informações de avaliação de reabilitação e salvá-las automaticamente no módulo de gerenciamento de informações. Conclusões: O sistema de avaliação e treinamento de discinesia baseado no Kinect projetado neste estudo pode aumentar a eficiência do treinamento de reabilitação para pacientes com discinesia, e é altamente sugerido na prática clínica. Nível de evidência II; Estudos terapêuticos- investigação dos resultados do tratamento.

RESUMEN Objetivo: El estudio llama la atención para el diseño de un sistema de evaluación de la discinesia utilizando el sensor Kinect para mejorar la eficiencia del entrenamiento de rehabilitación. Métodos: Diseño de la página de inicio de sesión. Paso 2: Configuración de las funciones del sistema. El contenido de la guía de movimiento relevante y el contenido de evaluación de la rehabilitación se incorporan en el sistema para hacer que la capacitación en rehabilitación sea eficiente y ordenada. Las funciones integrales de procesamiento, evaluación y exportación de datos son necesarias para proporcionar referencia a los médicos rehabilitadores en el diagnóstico y el tratamiento. Paso 3: Diseño de los módulos del sistema. Sobre la base de la configuración del sistema, se han diseñado y desarrollado los módulos funcionales correspondientes. Con cada módulo realizando sus funciones específicas, debe asegurarse que existe un cierto grado de correlación entre los módulos. Paso 4: El diseño del marco de la función del sistema. Resultados: Se diseña una página de inicio de sesión simple y cómoda; 2. El sistema es capaz de entrenamiento en rehabilitación y manejo de datos; 3. Los módulos específicamente diseñados incluyen el módulo de recolección de deportes, el módulo de capacitación en rehabilitación, el módulo de evaluación de la rehabilitación y el módulo de gestión de la información; 4. Después de iniciar sesión, el paciente debe buscar primero el plan de rehabilitación en el módulo de función de entrenamiento de rehabilitación y luego realizar el entrenamiento de rehabilitación con referencia al plan de rehabilitación. Kinect obtiene de forma sincrónica la información deportiva del paciente durante todo el proceso de entrenamiento, y los pacientes pueden obtener información sobre la evaluación de la rehabilitación y guardarla automáticamente en el módulo de gestión de información. Conclusiones: El sistema de evaluación y entrenamiento de discinesia basado en Kinect diseñado en este estudio puede aumentar la eficiencia del entrenamiento de rehabilitación para pacientes con discinesia, y está altamente recomendado en la práctica clínica. Nivel de evidencia II; Estudios terapéuticos- investigación de los resultados del tratamiento.

Hemibalismo en el síndrome hiperglucémico hiperosmolar no cetósico

RESUMEN Se trata de una paciente del sexo femenino de 71 años de edad con diagnóstico de diabetes mellitus tipo 2 en tratamiento irregular con antidiabéticos orales, que acude al Servicio de urgencias por movimientos anormales del hemicuerpo derecho, interpretados como hemibalismo con componentes coreicos, de 3 días de evolución. En el laboratorio se detecta hiperglicemia no cetósica y en la tomografía de cráneo se evidencia hiperdensidad en ganglios caudado y lenticular lado izquierdo. Tras el adecuado control de la glicemia y dosis bajas de haloperidol la paciente evolucionó favorablemente, con disminución de los movimientos anormales.

ABSTRACT This is a 71-year-old female patient with a diagnosis of type 2 diabetes mellitus undergoing irregular treatment with oral antidiabetics, who came to the emergency department due to abnormal movements of the right hemibody, interpreted as hemiballism with choreic components, with 3 days. of evolution. Nonketotic hyperglycemia is detected in the laboratory and hyperdensity in the caudate and lenticular ganglia on the left side is evidenced on the skull tomography. After adequate glycemic control and low doses of haloperidol, the patient evolved favorably, with a decrease in abnormal movements.

Jules Bernard Luys: from a description of the subthalamic nucleus to hypnotism / Jules Bernard Luys: da descrição do núcleo subtalâmico ao hipnotismo

ABSTRACT The authors review the role of Jules Bernard Luys in the discovery of the subthalamic nucleus (STN) over 150 years ago. The relationships between the STN and movement disorders, particularly hemiballismus and Parkinson's disease, are well known. The academic life of Jules Bernard Luys can be divided into two periods: a brilliant start as a neuroanatomist, culminating in the discovery of the STN, followed by a second period marked by a shift in his academic activity and an increased interest in topics such as hysteria, hypnotism and, eventually, esotericism.

RESUMO Os autores revisam o papel de Jules Bernard Luys na descoberta do núcleo subtalâmico (NST) há mais de 150 anos. As relações da NST com distúrbios do movimento, em particular o hemibalismo e a doença de Parkinson, são bem conhecidas. A vida acadêmica de Jules Bernard Luys pode ser dividida em duas fases: a primeira, um brilhante começo de sua carreira como neuroanatomista, culminando na descoberta do NST, seguido por um segundo período marcado por uma mudança em sua atividade acadêmica, e maior interesse em tópicos como histeria, hipnotismo e finalmente esoterismo.

Las diferentes facetas de la encefalitis autoinmune / The different facets of autoinmune encephalitis

RESUMEN INTRODUCCIÓN: La encefalitis autoinmune es causada por mecanismos inmunes antineuronales, su presentación clínica es heterogénea, los criterios clínicos y paraclínicos disponibles orientan el abordaje, sin embargo, el reto ocurre cuando no hay autoanticuerpos detectables en suero o líquido cefalorraquídeo (LCR). METODOLOGÍA: Reportamos cuatro casos destacando la variabilidad de las manifestaciones clínicas, que ante la ausencia de anticuerpos (negativos finalmente en tres de los casos) fueron tratados con inmunoterapia con buena respuesta. CONCLUSIÓN: En sitios donde no se dispone de medición de anticuerpos de manera expedita, o a pesar de ser estos negativos, ante la sospecha clínica, apoyado de estudios de LCR, resonancia magnética nuclear y registro electroencefalográfico, se sugiere iniciar inmunoterapia temprana, usualmente dando lugar a reversibilidad del trastorno neurológico.

SUMMARY INTRODUCTION: Autoimmune encephalitis is caused by antineuronal immune mechanisms, its clinical presentation is heterogeneous, clinical and paraclinical criteria guide the approach, however, the challenge occurs when there are no detectable autoantibodies in serum or cerebrospinal fluid. METHODOLOGY: We report four cases that highlight the variability of clinical manifestations, which in the absence of antibodies (finally negative in three of the cases) were treated with immunotherapy with good response. CONCLUSION: In places where antibody measurement is not available expeditiously, or despite it being negative, given clinical suspicion, supported by CSF studies, magnetic resonance imaging and electroencephalographic recording, it is suggested to start early immunotherapy, usually resulting in the reversibility of the neurological disorder.

Tos crónica y otitis recurrente. Discinesia ciliar primaria. Caso clínico / Chronic cough and recurrent otitis. Primary ciliary dyskinesia. Clinical case / Tosse crônica e otite recorrente. Discinesia ciliar primária. Caso clínico

Resumen: La tos en la infancia es un síntoma muy frecuente y constituye uno de los motivos de consulta más comunes en la práctica pediátrica diaria. En la mayoría de los casos la causa son infecciones respiratorias banales, pero todo niño con tos que persiste más allá de las cuatro a ocho semanas se considera que tiene tos crónica y debe ser evaluado para descartar patologías específicas. En caso de un síndrome canalicular exudativo persistente crónico y otitis recurrentes supuradas, debemos sospechar enfermedades respiratorias crónicas poco frecuentes que requieren una evaluación diagnostica ampliada, dentro de ellas la discinesia ciliar primaria (DCP). La DCP es una enfermedad de herencia principalmente autosómica recesiva, caracterizada por un defecto estructural de las células ciliadas presentes en el tejido respiratorio y gonadal, entre otros, que repercute en su función. Se presenta el caso de un adolescente de 13 años con tos catarral y otitis crónica serosa desde los 6 meses de vida, realizándose el diagnóstico de DCP a los 9 años por la clínica, imagenología, estudio de microscopía electrónica de transmisión y genético. Los métodos diagnósticos de confirmación son complejos en cuanto a su realización e interpretación y solo están disponibles en centros de referencia. El retraso de éstos se asocia a una peor calidad de vida a largo plazo.

Summary: Cough in childhood is a very frequent symptom and one of the most common reasons for consultation in pediatric practice. In most cases, it is secondary to mild respiratory infections, but if the symptom persists beyond 4 to 8 weeks, we should assess a case of chronic cough in order to rule out specific pathologies. For chronic persistent exudative and canalicular syndrome, and recurrent suppurative otitis, we should suspect rare chronic respiratory disease that needs a thorough diagnostic evaluation, including primary ciliary dyskinesia (PCD). PCD is mainly an autosomal recessive inheritance disease, characterized by a structural defect of the ciliary cells, which mostly affects the respiratory and gonadal tissues. We hereby introduce the clinical case of a 13-year-old girl with catarrhal cough and serous chronic otitis since 6 months of age and diagnosed with PCD at 9 years of age through clinical assessment, imaging, transmission electron microscopy (MET) and genetic studies. Diagnostic confirmation methods are complex to carry out and interpret, and are only available at reference centers. Diagnostic delay leads to a poorer quality of life.

Resumo: A tosse na infância é um sintoma muito comum e é um dos motivos mais comuns de consulta pediátrica. Na maioria dos casos, ela é causada por infecções respiratórias banais, mas toda criança com tosse persistente além de 4 a 8 semanas deverá ser avaliada como tosse crônica para descartar patologias específicas. No caso de Síndrome Canalicular Exsudativo Persistente Crônico e de Otite Recorrente Supurativa, devemos suspeitar de doenças respiratórias crônicas raras, as quais requerem uma avaliação diagnóstica extensa, incluindo a Discinesia Ciliar Primária (DCP). A DCP é uma doença de herança principalmente autossômica recessiva, caracterizada por um defeito estrutural das células ciliadas no tecido respiratório e gonadal, entre outros, que afeta a sua função. Apresentamos o caso de um adolescente de 13 anos com tosse catarral e otite serosa crônica a partir dos 6 meses de idade, o diagnóstico de DCP foi realizado aos 9 anos através de estudos clínicos e imaginológicos, com Microscópio Eletrônico de Transmissão (MET) e estudos genético. Os métodos de diagnóstico de confirmação são complexos de realizar e interpretar e estão disponíveis apenas nos Centros de Referência. O atraso na realização desses métodos está associado a uma pior qualidade de vida a longo prazo.

Trastornos por tics en niños: un caso con retraso diagnóstico / Tics disorders in children: a case with diagnostic delay

Resumen Un tic es un movimiento (tics motores) o sonido (tics vocal o fónico) breve, repentino y no rítmico. El DSM 5 define tres trastornos por tics: transitorios, vocales o motores persistentes y, el trastorno de la Tourette. Su diagnóstico es eminentemente clínico, siendo cruciales la historia clínica y la observación para realizar un adecuado diagnóstico diferencial con otros trastornos hipercinéticos del movimiento, tales como distonías, corea o atetosis, entre otros. Se presenta el caso de un niño de nueve años diagnosticado luego de dos meses de síntomas y de tratamientos inadecuados, quien mejoró luego de establecerse un diagnóstico correcto y ofrecerse terapia farmacológica dirigida.

Abstract A tic is a movement (motor tics) or sound (vocal or phonic tics) that is brief, sudden and not rhythmic. The DSM 5 defines three tics disorders: transient tics disorder, persistent (chronic) vocal or motor tics disorder, and Tourette's syndrome. Their diagnosis is mainly made through clinical history and observation. It is crucial to make an adequate differential diagnosis with other hyperkinetic disorders as dystonias, choreas or athetosis. We present the case of a 9-year-old boy diagnosed after 2 months of symptoms and inadequate treatments, who improved after establishing a correct diagnosis and offering targeted pharmacological therapy.

Discinesia paroxística não cinesiogênica: relato de caso / Paroxysmal non-kinesigenic dyskinesia: case report

Modelo do estudo: Relato de caso. Importância do problema e comentários: A discinesia paroxística não cinesiogênica é um tipo de discinesia paroxística. É caracterizada por movimentos involuntários unilaterais ou bilaterais, do tipo coreico, distônico, balístico ou misto. É uma desordem rara e o diagnóstico precoce é crucial para seu tratamento e melhoria na qualidade de vida do indivíduo. O presente estudo relata um caso de Discinesia Paroxística Não Cinesiogênica e seus achados clínicos, além de apresentar breve revisão da literatura (AU)

Study type: Case report. Relevance and comments: Paroxysmal non-kinesigenic dyskinesia is a type of paroxysmal dyskinesia. It is characterized by involuntary unilateral or bilateral movements, of the choreic, dystonic, ballistic or mixed type. It is a rare disorder and the early diagnosis is crucial for the treatment and improvement of the individual's quality of life. The present report illustrates a case of paroxysmal non-kinesigenic dyskinesia and clinical findings, as well as a brief review of the literature (AU)

Distúrbio de movimento por conta de estado hiperosmolar não cetótico em idosa: relato de caso / Movement disorder caused by hyperosmolar hyperglycemic state in an older adult: a case report

O diabetes e suas complicações constituem as principais causas de mortalidade precoce na maioria dos países. O envelhecimento da população e a crescente prevalência da obesidade e do sedentarismo, além dos processos de urbanização, são considerados os principais fatores responsáveis pelo aumento da incidência e da prevalência do diabetes mellitus (DM) em todo o mundo. Este relato de caso objetiva descrever a presença de distúrbio do movimento em idoso por conta do estado hiperosmolar não cetótico. A combinação de hemicoreia-hemibalismo, hiperglicemia não cetótica e envolvimento dos gânglios da base em exames de imagem é considerada uma síndrome única. Os distúrbios do movimento em estado hiperosmolar não cetótico apresentam resposta terapêutica satisfatória com o uso de neurolépticos e controle glicêmico adequado. A escassez de trabalhos publicados proporciona subdiagnósticos clínico e laboratorial, interferindo no prognóstico e no acompanhamento dos pacientes.

Diabetes mellitus (DM) and its complications constitute the leading causes of early mortality in most countries. Population aging and the growing prevalence of obesity and sedentary lifestyles, in addition to spreading urbanization, are considered the main drivers of the increasing incidence and prevalence of DM worldwide. This case report describes the acute onset of movement disorder in an older woman secondary to hyperosmolar hyperglycemic state (HHS). The combination of hemichorea­hemiballismus, HHS, and evidence of basal ganglia involvement on neuroimaging is considered a unique syndrome. Movement disorders secondary to HHS respond satisfactorily to administration of neuroleptic agents and proper glycemic control. The lack of published studies on this pathologic entity may lead to clinical and laboratory underdiagnosis, with negative impacts on patient prognosis and follow-up.

A novel frameshift mutation of PRRT2 in a family with infantile convulsions and choreoathetosis syndrome: c.640delinsCC (p.Ala214ProfsTer11)

The infantile convulsions and choreoathetosis (ICCA) syndrome is defined when two overlapping clinical features of benign familial infantile epilepsy (BFIE) and paroxysmal kinesigenic dyskinesia (PKD) are present in an individual or a family. Since the gene encoding proline-rich transmembrane protein 2 (PRRT2) was first identified in Han Chinese families with PKD, mutations of PRRT2 have additionally been reported in patients with BFIE and ICCA. We attempted to identify the genetic etiology in an ICCA family where the proband, her elder sister, and a maternal male cousin had BFIE, and her mother had PKD. Whole-exome sequencing performed in the proband and her sister and mother identified a novel pathogenic mutation of PRRT2 (c.640delinsCC; p.Ala214ProfsTer11), which was verified by Sanger sequencing. This frameshift PRRT2 mutation located near the genetic hot spot of base 649_650 results in the premature termination of the protein, as do most previously reported mutations in BFIE, ICCA, and PKD.

Effect of modified Gualou-Guizhi decoction combined with hyperbaric oxygen on muscle tension and motor function in stroke patients with spastic hemiplegia / 国际中医中药杂志

Objective@#To observe the effect of modified Gualou-Guizhi decoction combined with hyperbaric oxygen on muscle tension and motor function in stroke patients with spastic hemiplegia.@*Methods@#A total of 70 stroke patients with spastic hemiplegia met the inclusion criteria were randomly divided into the observation group and the control group, with 35 in each group. The control group was given the conventional treatment and hyperbaric oxygen treatment, while the observation group was treated with Gualou-Guizhi decoction on the basis of the control group. Lindmark scale was used to assess limb motor function, Fugl-Meyer Assessment Scale (FMA) was used to assess the degree of limb motor dysfunction, and Modified Ashworth Scale (MAS) was used to assess muscle tension. The root mean square (RMS) and frequency median (FM) of surface electromyography of quadriceps femoris were measured by automatic electromyography, and the clinical efficacy was evaluate.@*Results@#The total effective rate of the observation group was 91.4% (32/35), and the total effective rate of the control group was 71.4% (25/35). The total effective rate of the 2 groups was statistically significant (χ2=4.629, P=0.0314). After treatment, the scores of motor coordination ability and sensory function in the observation group were significantly higher than those in the control group (t value were 5.936, 5.182, all Ps<0.05), the FMA scores of upper and lower limbs were significantly higher than those in the control group (t value were 12.310, 11.996, all Ps<0.01), and the score of improved Ashworth muscle strength scale was significantly lower than that in the control group (t=5.083, P=0.031). After treatment, the EMG RMS (79.13 ± 7.02 vs. 68.45 ± 7.01 , t=5.697), FM (99.31 ± 9.65 Hz vs. 90.73 ± 9.49 Hz, t=5.382) of the observation group were significantly higher than those of the control group (P<0.05).@*Conclusions@#The application of Gualou-Guizhi decoction add and subtract combined with hyperbaric oxygen on muscle tension and motor function in stroke patients with spastic hemiplegia can improve the muscle strength of stroke hemiplegic patients and improve the motor dysfunction of the patients, which can help to promote the recovery of the movement function of the patientst.

Trastornos Paroxísticos No Epilépticos En Pre-Escolares / Non-epileptic paroxysmal disorders in pre-school children

Los trastornos paroxísticos no epilépticos son comunes en la población de niños pre-escolares. Estas condiciones incluyen una variedad de eventos cuyas manifestaciones y fisiopatología son muy distintas. Por esa razón, el diagnóstico puede representar un difícil reto. En algunas ocasiones, estudios como el EEG o la polisomnografía pueden ayudar a clarificar el diagnóstico y descartar un trastorno epiléptico. Sin embargo, la historia clínica y el examen físico suelen ser suficientes para llegar al diagnóstico correcto. En este artículo, presentamos información sobre los trastornos paroxísticos no epilépticos más comunes en la población de niños pre-escolares, incluyendo: tics, discinesias, eventos relacionados al sueño, etc. Además, discutimos estrategias para el diagnóstico y opciones de tratamiento.

Paroxysmal events are commonly encountered in toddlers. These events include a variety of conditions with different manifestations and pathophysiology. For that reason, the diagnosis of these events can be challenging. In some instances, studies such as EEG and polysomnogram may be useful to differentiate between epileptic and non-epileptic events. In the majority of cases, a complete clinical history is enough to make an appropriate diagnosis. In this article, we review some of the most common paroxysmal non-epileptic events affecting toddlers, such as: tics, dyskinesias, sleep related events, etc. We also discuss diagnostic strategies and treatment options.

Efectividad del uso de seating de posicionamiento en niños con parálisis cerebral discinética: revisión sistemática / Effectiveness of the use of seating devices in children with dyskinetic cerebral palsy: a systematic reviewx

Introduction: To assess the effectiveness of seating devices during the sitting position on postural stability and upper limb functionality in users with dyskinetic type cerebral palsy. Method: A systematic review that included randomized, quasi-randomized, cohort, and pre-post intervention clinical trials with evaluation before and after the intervention. This review included studies of chil-dren with a diagnosis of cerebral palsy, mainly of the dyskinetic type, with ages between 2 and 10 years old. The databases of CINAHL Plus, Cochrane (Central), EMBASE (Via Ovid), Virtual Health Library, OT Seeker, Medline (Via PubMed) and OpenGrey were used. Results: Two studies met the inclusion criteria; however, the analysis was carried out qualitatively due to the methodological quality for these, with presence of a high risk of bias. The study by Cimolin described greater trunk stability and smooth upper extremity movements with the use of a dynamically configured seat. Nwaobi described better upper extre-mity functionality in a seat inclined at 0º and 30º, not referring to trunk stability. Conclusion: From the review of the results it is concluded that there is not enough scientific evidence to determine that the use of seating devices favors the postural control and the functionality of upper extremities in children with cerebral dyskinesia type cerebral palsy.

Introducción: Evaluar la eficacia del posicionamiento sedente en la estabilidad postural y funcionalidad de extremidades superiores, en ni-ños con parálisis cerebral discinética, comparando el uso y el no uso de seating de posicionamiento. Método: Revisión siste-mática incluyendo ensayos clínicos de tipo aleatorio, cuasialeatorizado, de cohorte y casos con evaluación antes y después de la intervención. Se incluyó niños con parálisis cerebral discinético, entre 2 y 10 años de edad. Se utilizó bases de datos de CI-NAHL Plus, Cochrane (Central), EMBASE (Vía Ovid), Biblioteca Virtual de la Salud, OT Seeker, Medline (Via PubMed) y Open Grey. Resultados: Dos estudios cumplieron criterios de inclusión, aunque el análisis se realizó de forma cualitativa por la calidad metodológica de estos. Cimolin detectó mayor estabilidad de tronco y suavidad en los movimientos de extremidades superiores con el uso de un asiento de configuración dinámica. Nwaobi describió mejor funcionalidad de extremidad superior en un asiento inclinado a 0º y 30º, no haciendo referencia a la estabilidad de tronco. Conclusión: De la revisión de los resulta-dos, se concluye que no existe evidencia científica suficiente que determine que el uso de seating favorezca o no el control postural y la funcionalidad de extremidades superiores en niños y jóvenes con parálisis cerebral de tipo discinética.

Farmacovigilancia activa de metoclopramida 10 mg oral en pacientes del Programa de Alivio del Dolor y Cuidados Paliativos o diabetes mellitus tipo 2 en cinco hospitales del Servicio de Salud Viña del Mar-Quillota / Extrapyramidal adverse reactions to metoclopramide: a pharmacovigilance survey

Background: In 2013 the Chilean regulatory sanitary agency issued a warning concerning dose adjustment and use restriction to avoid severe adverse effects of metoclopramide such tardive dyskinesia. Aim: To study dyskinesia type adverse effects in a population using metoclopramide. Material and Methods: A cross sectional observational study was conducted among patients pertaining to palliative care and diabetes mellitus programs and consuming 10 mg/day or more of metoclopramide. Patients were interrogated looking for extrapiramidal signs and symptoms using a questionnaire validated by two neurologists. Results: In 40% of diabetic patients with gastroparesia and 35% of palliative care patients, extrapyramidal adverse reactions to metoclopramide were suspected. Palliative Care patients suffered the largest number of adverse events. The period of use and individual doses of the drug were largely above Chilean regulatory agency recommendations in all cases. Conclusions: A significant number of patients using metoclopramide could experience extrapyramidal adverse reactions.

Role Of Withania Somnifera And It’s Active Principle Withanolide-a In Balance And Motor Co-ordination By Foot Print Test

Background: The basal ganglia historically been considered as a part of the motor system because of the varietyof motor deficits that occur when they are damaged. But now it is considered as “extrapyramidal” motor system,and the disorders of basal ganglia are called extrapyramidal disorders. One type of symptoms that result frombasal ganglia disorders is called as Huntington’s Chorea. As this disorder involves with symptoms like dyskinesias- abnormal involuntary movements, we felt it is necessary to protect our nervous system from such a disorder ifpossible in a painless regular fashion by a herb.Materials and Methods: We used adult male Sprague Dawly rats for this study. Animals were divided into 5groups and were given either Withania somnifera extract or the active component Withanolide A in differentconcentrations 10 days prior to lesion surgery and continued 5 days post surgery. The neuroprotective role of thedrug employed was analyzed on the 5th day post lesion by using foot print test in a run way.Result: The gait and balance of the animals were taken as a measure to analyze the protective nature of thestriatum and so the activity of the drug employed here. The gait and balance of the LC animals were poor statingthe unprotective nature of striatum. But the balance and gait of both drug group animals were comparativelybetter than the LC animals. That clearly stated the neuroprotective capacity of both the drugs used for this study.Conclusion: Based on the observations and results we came to a conclusion that both the ethanolic extract andthe active component withanolide A have the capacity in protecting the striatum and so can be used as a foodsupplement on a daily basis to protect our striatum. If needed further research can be conducted to analyze deepinto the therapeutic effects of these herbal drugs.